Alaunos Therapeutics reported $400K in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Alaunos Therapeutics USD 400K 213K Mar/2026
Amgen USD 19.52B 1.37B Mar/2026
AstraZeneca USD 22.51B 2.78B Mar/2026
Baxter International USD 1.09B 87M Mar/2026
Biogen USD 358.5M 73.5M Mar/2026
Bioline Rx USD 5.66M 2.2M Sep/2025
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Celltrion KRW 78.68B 25.51B Dec/2025
Corcept Therapeutics USD 33.31M 7.14M Mar/2026
Cspc Pharmaceutical CNY 2.32B 236.83M Dec/2025
Curis USD 5.61M 1.52M Dec/2025
Deva Holding AS TRY 809.81M 105.88M Sep/2023
Dianthus Therapeutics USD 5.27M 4.45M Mar/2026
Divis Laboratories Ltd INR 10.4B 1.3B Sep/2025
Gilead Sciences USD 645M 70M Mar/2026
GlaxoSmithKline GBP 14.34B 1.05B Mar/2026
Incyte USD 228.62M 1.41B Mar/2026
Intrexon USD 4.85M 3.12M Jun/2024
Ionis Pharmaceuticals USD 26.03M 2.05M Mar/2026
J&J USD 10.46B 1.53B Mar/2026
Kangmei Pharma CNY 2.61B 176.42M Sep/2025
Karyopharm Therapeutics USD 4M 1.39M Dec/2025
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
Laboratorios Farma EUR 107.59M 341K Dec/2023
Malin Corporation EUR 700K 200K Dec/2024
Medical Developments International AUD 4.31M 2.18M Dec/2025
Merck USD 3.86B 541M Mar/2026
Neuren Pharmaceuticals AUD 2.4M 4.26M Dec/2025
Novartis USD 4.32B 134M Mar/2026
Organigram Holdings CAD 71.08M 18.17M Dec/2025
Ovoca Bio EUR 186K 23K Jun/2025
Pfizer USD 4.51B 734M Mar/2026
Pharma Mar EUR 43.83M 10.51M Mar/2026
PTC Therapeutics USD 25.48M 20M Mar/2026
Qiagen NV USD 72.66M 2.11M Dec/2025
Regeneron Pharmaceuticals USD 1.03B 4.81B Mar/2026
Roche Holding CHF 5.78B 1.27B Dec/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sartorius EUR 345.3M 2.2M Mar/2026
Sino Biopharmaceutical CNY 2.82B 1.32B Jun/2025
TG Therapeutics USD 148.84M 41.34M Mar/2026
Tilray USD 114.5M 3.69M Sep/2025
Verastem USD 12.45M 2.56M Dec/2025
Zealand Pharma A/S 346.6M 102.71M Dec/2025
Zz Pientze Pharmaceu CNY 457.05M 59.09M Mar/2026